See more : Buzzi Unicem S.p.A. (BZZUF) Income Statement Analysis – Financial Results
Complete financial analysis of HEXO Corp. (HEXO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HEXO Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Shijiazhuang Shangtai Technology Co., Ltd. (001301.SZ) Income Statement Analysis – Financial Results
- QuoteMedia, Inc. (QMCI) Income Statement Analysis – Financial Results
- Armada Hoffler Properties, Inc. (AHH-PA) Income Statement Analysis – Financial Results
- Robert Half International Inc. (RHI) Income Statement Analysis – Financial Results
- Kerjaya Prospek Group Bhd (7161.KL) Income Statement Analysis – Financial Results
HEXO Corp. (HEXO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hexocorp.com
About HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 191.10M | 123.77M | 80.78M | 47.54M | 4.93M | 4.10M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 266.78M | 74.97M | 138.76M | 20.62M | -1.47M | -2.35M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -75.67M | 48.80M | -57.98M | 26.93M | 6.40M | 6.45M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -39.60% | 39.43% | -71.77% | 56.64% | 129.72% | 157.39% | 0.00% | 0.00% | 0.00% |
| Research & Development | 3.22M | 3.84M | 4.64M | 2.82M | 0.00 | 86.38K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 99.31M | 69.92M | 78.58M | 73.96M | 14.37M | 4.27M | 0.00 | 29.29K | 29.29K |
| Selling & Marketing | 22.93M | 10.35M | 12.47M | 31.19M | 8.34M | 2.99M | 0.00 | 0.00 | 0.00 |
| SG&A | 122.24M | 80.27M | 91.06M | 105.15M | 22.71M | 7.25M | 0.00 | 29.29K | 29.29K |
| Other Expenses | 28.78M | 8.15M | 322.88M | 3.51M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 154.24M | 92.25M | 418.58M | 111.48M | 24.37M | 7.93M | 0.00 | 29.29K | 29.29K |
| Cost & Expenses | 421.01M | 167.22M | 557.34M | 132.10M | 22.90M | 5.58M | 0.00 | 29.29K | 29.29K |
| Interest Income | 1.65M | 1.60M | 1.90M | 5.19M | 2.12M | 92.16K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 20.07M | 32.12M | 10.04M | 469.00K | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 810.10M | 16.73M | 68.25M | 5.85M | 1.66M | 591.65K | 22.82K | 0.00 | 0.00 |
| EBITDA | -257.63M | -26.73M | -476.55M | -78.70M | -14.19M | -1.75M | 0.00 | -29.29K | -29.29K |
| EBITDA Ratio | -134.81% | -21.59% | -589.91% | -165.55% | -287.60% | -42.73% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.07B | -43.45M | -476.55M | -84.56M | -17.97M | -1.48M | 0.00 | -29.29K | -29.29K |
| Operating Income Ratio | -558.72% | -35.11% | -589.91% | -177.86% | -364.14% | -36.21% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -691.53M | -71.71M | -75.96M | -847.00K | -5.38M | -10.93M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.11B | -115.16M | -552.51M | -85.40M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Income Before Tax Ratio | -582.11% | -93.04% | -683.94% | -179.64% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.81M | -397.00K | -6.02M | -3.84M | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Net Income | -1.07B | -114.76M | -546.49M | -81.56M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Net Income Ratio | -561.80% | -92.72% | -676.48% | -171.57% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| EPS | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| EPS Diluted | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| Weighted Avg Shares Out | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
| Weighted Avg Shares Out (Dil) | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
HEXO to Host Second Quarter 2023 Earnings Conference Call
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio only conference call on March 17, 2023, at 10 a.m. EDT, to review...
Are Canadian Cannabis Stock A Buy In March? 3 To Watch This Week
Canadian Pot Stocks For Watchlist This Week The post Are Canadian Cannabis Stock A Buy In March? 3 To Watch This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Best Canadian Marijuana Stocks To Watch Under $2
Best Canadian Pot Stocks To Watch In March? The post Best Canadian Marijuana Stocks To Watch Under $2 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Canadian Marijuana Stocks For 2023? 3 Penny Stocks To Watch
Are You Watching Canadian Pot Stocks? The post Canadian Marijuana Stocks For 2023? 3 Penny Stocks To Watch appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Marijuana Penny Stocks With The Best Year To Date Performance In 2023
Top Penny Pot Stocks Under $2 For Traders In March The post Top Marijuana Penny Stocks With The Best Year To Date Performance In 2023 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Top Marijuana Stocks To Watch On The Nasdaq Before March
Are Canadian Cannabis Stocks On Your List For March? The post Top Marijuana Stocks To Watch On The Nasdaq Before March appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
HEXO annonce une augmentation de la production de ses populaires joints droits préroulés et le lancement d’une technologie d’inhalation améliorée
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp (TSX : HEXO ; NASDAQ : HEXO) (« HEXO » ou la « Société »), un important producteur de produits de cannabis de première qualité, est heureuse d’annoncer qu’elle a achevé avec succès l'expansion de sa...
HEXO Increases Production of Its Popular Straight Edge Pre-Rolls and Launches Enhanced Inhalation Technology
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, is pleased to announce it has successfully completed the expansion of its straight edge pre-roll production capacity at the Company's Fenwick,...
HEXO Increases Production of Its Popular Straight Edge Pre-Rolls and Launches Enhanced Inhalation Technology
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, is pleased to announce it has successfully completed the expansion of its straight edge pre-roll production capacity at the Company’s Fenwick,...
HEXO Announces Election of Directors
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO”), a leading producer of high-quality cannabis products, today announced that at the annual general meeting of shareholders held on January 31, 2023 (the “Meeting”), each of the eight director nominees was...
Source: https://incomestatements.info
Category: Stock Reports